Trials / Completed
CompletedNCT03908580
MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity
A Prospective, Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Treatment of Post Stroke Upper Limb Spasticity
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is "A Prospective, Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Treatment of Post Stroke Upper Limb Spasticity".
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meditoxin | Meditoxin® (Botulinum toxin type A) was injected up to 360 U. |
Timeline
- Start date
- 2013-09-06
- Primary completion
- 2014-10-31
- Completion
- 2015-03-31
- First posted
- 2019-04-09
- Last updated
- 2019-04-09
Source: ClinicalTrials.gov record NCT03908580. Inclusion in this directory is not an endorsement.